Skip to main content

and
  1. No Access

    Chapter and Conference Paper

    High-dose chemotherapy with hematologic rescue for high-risk non-seminomatous germ cell tumors

    Despite progress in the treatment of disseminated non-seminomatous germ cell tumors (NSGCT), 20–30%of patients do not achieve CR or relapse [1]. We evaluated high-dose chemotherapy (HDC) followed by autologous...

    J. L. Pico, J. P. Droz, E. Zambon in Proceedings of the 3rd International Congr… (1991)